Pharmacological validation of TDO as a target for Parkinson's disease.

Autor: Perez‐Pardo, Paula1 (AUTHOR), Grobben, Yvonne2 (AUTHOR), Willemsen‐Seegers, Nicole2 (AUTHOR), Hartog, Mitch1 (AUTHOR), Tutone, Michaela1 (AUTHOR), Muller, Michelle2 (AUTHOR), Adolfs, Youri3 (AUTHOR), Pasterkamp, Ronald Jeroen3 (AUTHOR), Vu‐Pham, Diep2 (AUTHOR), Doornmalen, Antoon M.2 (AUTHOR), Cauter, Freek2 (AUTHOR), Wit, Joeri2 (AUTHOR), Gerard Sterrenburg, Jan2 (AUTHOR), Uitdehaag, Joost C.M.2 (AUTHOR), Man, Jos2 (AUTHOR), Buijsman, Rogier C.2 (AUTHOR), Zaman, Guido J.R.2 (AUTHOR) guido.zaman@ntrc.nl, Kraneveld, Aletta D.1 (AUTHOR)
Zdroj: FEBS Journal. Jul2021, Vol. 288 Issue 14, p4311-4331. 21p.
Databáze: Academic Search Ultimate